Shares of Informa plc (LON:INF – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the seven research firms that are presently covering the stock, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation and five have issued a buy recommendation on the company. The average 1-year price target among analysts that have issued a report on the stock in the last year is GBX 865.33 ($11.00).
A number of equities analysts have recently commented on INF shares. Berenberg Bank reissued a “buy” rating and set a GBX 975 ($12.39) price target on shares of Informa in a report on Monday, March 11th. Shore Capital reissued a “buy” rating on shares of Informa in a report on Thursday, April 4th. Finally, Numis Securities reaffirmed a “buy” rating and set a GBX 922 ($11.72) price target on shares of Informa in a report on Friday, March 8th.
Check Out Our Latest Report on Informa
Insider Transactions at Informa
Informa Stock Performance
Shares of LON:INF opened at GBX 860 ($10.93) on Friday. Informa has a 1 year low of GBX 684 ($8.69) and a 1 year high of GBX 874.16 ($11.11). The stock has a market capitalization of £11.61 billion, a price-to-earnings ratio of 2,866.67, a price-to-earnings-growth ratio of 0.75 and a beta of 1.10. The company has a debt-to-equity ratio of 25.84, a current ratio of 0.59 and a quick ratio of 1.70. The company’s 50 day simple moving average is GBX 830.33 and its 200 day simple moving average is GBX 806.06.
About Informa
Informa plc operates as an international events, digital services, and academic knowledge company in the United Kingdom, Continental Europe, North America, China, and internationally. It operates through four segments: Informa Markets, Informa Tech, Informa Connect, and Taylor & Francis. The Informa Connect segment delivers specialist content, and live events and on-demand experiences for professionals through in-person, live, and digital platforms and services that enables businesses and professionals to meet, network, discuss, and learn.
Featured Stories
- Five stocks we like better than Informa
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Sarepta Therapeutics Stock Soars on FDA Approval
- 3 Grocery Stocks That Are Proving They Are Still Essential
- CarMax: A Market Melt-Up Waiting to Happen for this Stock
- ESG Stocks, What Investors Should Know
- 3 Solar Stocks to Watch that are Building the Green Energy Future
Receive News & Ratings for Informa Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Informa and related companies with MarketBeat.com's FREE daily email newsletter.